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Abstract
Themyofibroblast is an important stromal cell of the gastrointestinal tract. Current in vitro and
in vivomodels either do not accurately recreate stromal-epithelial interactions or are not spe-
cific to myofibroblasts. We sought to create an animal model that would allow the study of
myofibroblast-epithelial interactions. We isolated and cultured colonic myofibroblasts from
FVBmice. Cells were α-SMA and vimentin positive but desmin negative on immunoblot anal-
ysis. We injected the myofibroblasts into the colonic submucosa of syngeneic adult mice (n =
8) via a miniendoscopic system. We then isolated green fluorescent protein (GFP) positive
colonic myofibroblasts from C57BL/6-Tg(CAG-EGFP)1Osb/J mice and injected them into the
colonic lamina propria of C57BL/6J mice at 1x105 (n = 14), 1x106 (n = 9), or 5x106 cells/mL
(n = 4). A subset of mice were injected with serum-free media and ink without cells (n = 3).
Mice underwent repeat endoscopy and euthanasia one or 7 days after injection. Colons were
isolated and either fixed in 10% formalin or the inked sites were individually excised and lysed
for DNA.We assessed the injection sites via histology and immunohistochemical stains for α-
SMA and GFP.We used qPCR to quantify GFP DNA transcripts at the lamina propria injec-
tion sites. Submucosal injection of myofibroblasts resulted in the formation of a subepithelial
wheal on endoscopy, which persisted to day 7. Myofibroblasts injected either into the submu-
cosa or lamina propria maintained viability on post-injection day 7 as evidenced by positive α-
SMA staining. qPCR of lamina propria injections showed a dose-dependent increase in GFP
DNA transcripts on post-injection day 1, whereas the number of transcripts on day 7 was
equivalent for the concentrations injected. We demonstrate short-term survival of primary cul-
tured colonic myofibroblasts in syngeneic mice. This may prove to be a valuable model for
studying the role of myofibroblasts in states of health and disease.
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Introduction
The myofibroblast is an important stromal cell of the gastrointestinal (GI) tract that is believed
to be involved in the regulation of many physiologic processes [1,2] ranging from intestinal
stem cell differentiation and migration along the crypt-villus axis, mucosal repair, fibrosis, and
the development of cancer [3–6]. The signaling mechanisms that regulate myofibroblast func-
tion have been studied in vitro, using both cell lines and primary cells taken from murine and
human colon [1,2,7]. However, few in vivo models exist that allow the study of myofibroblast
signal modulation on the overlying epithelium directly.
In-depth analysis of myofibroblast physiology requires the ability to not only study these
cells in vitro, but to evaluate how changes in myofibroblast function impact surrounding cell
populations and the overall function of the GI tract in an in vivo setting. Existing cell culture
and animal models are limited in their ability to effectively study cell-cell interactions. In vitro
co-culture models are often unable to recreate the interactions found in nature accurately, they
poorly mimic actual physiologic conditions, and underestimate the contributions of the normal
bowel wall architecture and surrounding cell populations that are essential elements of the GI
microenvironment [5]. Animal models that utilize conditional gene targeting are neither
organ- nor cell type-specific [8–10], since myofibroblasts lack a unique cell marker [8,9].
Unlike other GI tract organs, the mouse colon is accessible by endoscopy for evaluation of
its mucosal surface without the need for surgical procedures or the sacrifice of animals. Endos-
copy is not limited to visual inspection of the bowel wall, but provides a means for tissue sam-
pling and other interventional procedures that are commonly performed in human patients.
Utilizing a small animal colonoscope, the goal of our study was to develop a minimally inva-
sive, reproducible, and well-tolerated technique for subepithelial implantation of primary myo-
fibroblasts into the colon wall of live, immune-competent, syngeneic mice.
In this study we describe a novel technique that has the potential to allow for the real-time
in vivo study of stromal-epithelial cell interactions. The technique first involves the isolation of
primary myofibroblasts from mouse colon tissue, using a well-established technique [11].
These cells can be grown in cell culture, and they have been previously shown to maintain via-
bility following subcutaneous injection into immune-compromised animals [5]. Based on these
observations, we hypothesized that that primary myofibroblasts might survive following injec-
tion into the colon wall if we employed a technique that has been previously described using
cancer cell lines [12]. In the present study, we utilized standard colonoscopic techniques to im-
plant primary myofibroblasts into the submucosa and lamina propria of the mouse colon wall.
We demonstrate that myofibroblasts can be successfully and reproducibly implanted in the
colon wall and maintain short-term viability in immune-competent, syngeneic mice.
Methods
Myofibroblast Isolation and Culture
Mouse colonic myofibroblasts were isolated from male or female 8–12 week old FVB mice
(Jackson Laboratory, Bar Harbor, ME) as previously described [13]. Briefly, the colon was
washed with ice cold sterile PBS and then shaken five times for 15 min in HBSS containing
5 mM EDTA, which de-epithelialized the tissue. Next, the tissue was incubated in 20 ml of
RPMI-5 [RPMI with 5% FCS, 10 mMHEPES, 2 mM L-glutamine, 1 mM sodium pyruvate,
100 U/ml Pen-Strep] containing 10.5 mg of dispase (GIBCO-Invitrogen, Carlsbad, CA) and
7.2 mg of collagenase D (Roche Diagnostics, Indianapolis, IN) for 2 h in a shaking 37°C incu-
bator. The digested tissue was treated with ACK lysis buffer for 5 min, and then was passed
through a 70-μm cell strainer into 100-mm dishes in RPMI-5. After a 3-hour incubation, the
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non-adherent cells were washed away; leaving adherent cells that consisted mainly of macro-
phages, epithelial cells, and myofibroblasts. After several days, the macrophages and epithelial
cells died off leaving cells that were morphologically homogeneous and composed primarily of
cells with a myofibroblast phenotype. These cells stained positive for both α-SMA and vimen-
tin but negative for desmin on immunoblot analysis. For the in vivo experiments, primary
myofibroblasts were used 1–2 weeks after initial isolation.
Myofibroblasts were also isolated from C57BL/6-Tg(CAG-EGFP)1Osb/J mice that constitu-
tively express the green fluorescent protein (GFP), originally obtained from the Jackson Labo-
ratory (Bar Harbor, ME) and bred at our institution.
Development of an Endoscopic Approach for Subepithelial
Myofibroblast Injections
Endoscopic procedures were performed on anesthetized 8 to 12 week old male and female FVB
(n = 8) or C57BL/6J (n = 30) mice using a 1.9 mm Karl Storz Coloview miniendoscopic system
(Karl Storz, Tuttlingen, Germany, Fig 1A) after placing the mice on a water-only diet
Fig 1. (A) Miniature endoscope. (B) Custom-made injection needle with a 30 gauge stainless steel tip. (C) Pulled and beveled capillary tubing for
subepithelial injection. Scale bar 50 μm.
doi:10.1371/journal.pone.0127258.g001
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overnight. Anesthesia was induced with a vaporizer using 3% isoflurane which was decreased
to 1% for maintenance.
For submucosal injections, a specially designed needle was created (Fig 1B) by brazing a
2-cm long 30-gauge needle to the end of a 10-cm long 26-gauge stainless steel needle (McMas-
ter Carr, Santa Fe Springs, CA). The 30-gauge tip was small enough to reliably enter the sub-
mucosal space, while the 26-gauge extension provided enough length to pass through the
working port of the endoscopic sheath.
For lamina propria injections, a micropipette was fabricated using glass capillary tubing
with OD 0.84 mm and ID 0.60 mm (King Precision Glass, Claremont, CA), which was pulled
with a vertical micropipette puller (David Kopf Instruments, Tujunga, CA) with a heated coil
in a two-step fashion at 14 and 16 amperes, respectively, and fitted onto the metal needle. The
tip diameter was approximately 2 μmwide (Fig 1C). The tip was beveled under a dissecting mi-
croscope using a computer hard drive spinning spun at 5,400 rpm that was radially etched with
600-grit sandpaper [14].
To confirm that injections could successfully be placed in the submucosa and lamina pro-
pria layers of the colon wall, initial experiments were performed using Spot (GI Supply, El
Paso, TX), a sterile, biocompatible non-India-ink-based permanent carbon ink suspension
used to “tattoo” the colon wall. Submucosal injections were carried out by inserting the tip of
the 30-gauge needle into the colon wall. A submucosal wheal confirmed successful injection
into the submucosal space. On the other hand, for successful lamina propria injections, the mi-
cropipette bevel was pushed against the colon wall while injecting and the presence of a punc-
tate spot of ink was confirmed; presence of a wheal would suggest a deeper injection into
the submucosa.
For subepithelial injection of myofibroblasts, cells were suspended in low glucose DMEM
(Life Technologies) without serum. To facilitate later identification of the injection sites, 1.5%
Spot was added to the cell suspensions. For submucosal injections, 100 μL of either DMEM
(n = 4) or myofibroblast suspension at a concentration of 5x105 cells/mL (n = 4) was injected.
For lamina propria injections, the ventral rectum and colon were injected with several μL of ei-
ther DMEM alone (n = 3) or GFP-positive myofibroblasts at a concentration of 1x105 (n = 14),
1x106 (n = 9), or 5x106 cells/mL (n = 4).
After the procedure, all mice were monitored for appropriate recovery from anesthesia and
placed back in standard laboratory mouse cages with full access to water and chow. Mice un-
derwent repeat colonoscopy 1 or 7 days later and then were euthanized with isoflurane over-
dose and colon specimens were isolated.
Whole-mount Fluorescence Microscopy
Colons of mice that had been injected with GFP-positive myofibroblasts were harvested,
opened on the mesenteric aspect and placed onto an ice-cold glass slide with the mucosa facing
downward. Ink-laden areas were examined using a fluorescent microscope.
Histology and Immunohistochemistry (IHC)
Near-confluent myofibroblasts cultured on 0.95 cm2 wells were fixed with 10% buffered forma-
lin for 10 minutes at room temperature prior to immunostaining. Isolated mouse colons were
flushed with cold PBS then filled with 60 °C Histogel (American MasterTech, Lodi, CA) and
fixed overnight in 10% buffered formalin solution. Specimens were embedded in paraffin and
sectioned at 3 μm thickness. Hematoxylin and eosin (H&E) staining and IHC were performed
per standard protocol. Heat-mediated antigen retrieval was performed in boiling Citra buffer
(Fisher Scientific, Pittsburgh, PA) for 20 minutes. For biotinylated stains, sections were stained
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with prediluted monoclonal mouse anti-α-smooth muscle actin antibody (α-SMA), biotiny-
lated secondary antibody, and streptavidin-horseradish peroxidase (all from Dako, Carpinteria,
CA). For immunofluorescence, slides were stained with polyclonal rabbit anti-α-SMA (Abcam,
Cambridge, MA) at 1:100 dilution, monoclonal rabbit anti-vimentin antibody (Abcam) at
1:250 dilution, monoclonal mouse anti-human desmin antibody (Dako) at 1:100 dilution, and
chicken anti-green fluorescent protein antibody (Aves Labs, Tigard, OR) at 1:500 dilution. Pri-
mary antibodies were conjugated with 1:200 dilution of goat anti-rabbit or anti-mouse antibod-
ies (Life Technologies, Grand Island, NY) or goat anti-chicken IgY antibody (Aves Labs). All
antibodies were diluted in blocking solution consisting of 2% BSA and 4% normal goat serum.
Slides were counterstained with 4',6-diamidino-2-phenylindole (DAPI; Life Technologies).
Quantitative PCR
Injected areas of the colon identified by black ink staining were isolated and individually placed
in 200 μL buffer ATL with 10% proteinase K (Qiagen, Valencia, CA) at 60 °C for at least
1 hour. DNA was extracted with the DNeasy blood and tissue kit (Qiagen). Quantitative PCR
(qPCR) was performed using a GFP TaqMan probe (Life Technologies). To convert the qPCR
data to number of GFP-positive DNA transcripts, a DNA ladder was constructed by perform-
ing qPCR on extracted DNA from a known number of GFP-positive myofibroblasts (range
1x102 to 1x106).
Western Blot
Confluent mouse myofibroblasts were lysed in 2x SDS-PAGE sample buffer (20 mM TrisHCl
pH 6.8, 6% SDS, 2 mM EDTA, 4% 2-mercaptoethanol, and 10% glycerol) and boiled for
10 min. After SDS-PAGE, proteins were transferred to Immobilon-P membranes. The transfer
was carried out at 100 V, 0.4 A at 4°C for 5 hours using a Bio-Rad transfer apparatus. The
transfer buffer consisted of 200 mM glycine, 25 mM Tris, 0.01% SDS, and 20% CH3OH. For
detection of proteins, membranes were blocked using 5% nonfat dried milk in PBS (pH 7.2)
and then incubated for 2 hours with the desired antibodies diluted in PBS (pH 7.2) containing
3% nonfat dried milk. Primary antibodies bound to immunoreactive bands were visualized by
ECL detection with horseradish peroxidase-conjugated anti-mouse or anti-rabbit antibodies
(GE Healthcare, Piscataway, NJ).
Data Analysis
Immunofluorescence and bright-field images were analyzed using ImageJ (National Institutes
of Health, Bethesda, MD). PCR data was analyzed in Excel (Microsoft Corporation, Redmond,
WA) and reported as mean ± standard deviation. Statistical analysis was performed with the
Wilcoxon signed-rank with p<0.05 assumed to be significant.
Ethics Statement
All animal studies were approved by the animal research committee at UCLA (ARC #2004–
016, 2012–038, and 2012–077). The UCLA animal facility is accredited by the AALAC. This
study was carried out in accordance with the recommendations in the Guide for the Care and
Use of Laboratory Animals of the National Institutes of Health.
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Results
Characterization of Colonic myofibroblasts
Primary mouse colonic myofibroblasts were isolated using a well-established technique
[7,13,15]. Cultured colonic myofibroblasts took a stellate appearance when grown in culture
(Fig 2A and 2B). Western blot analysis showed that cultured FVB mouse colonic myofibro-
blasts were positive for both α-SMA and vimentin while contamination with desmin-positive
smooth muscle cells was low (Fig 2C). Colonic myofibroblasts cultured from C57BL6 mice
showed the same expected staining pattern (S1 Fig). In this figure, the positive control stains
were performed on small intestine.
Endoscopic Model and Injection into the Submucosa and Lamina
Propria
Mice tolerated the colonoscopy procedure well. The rate of colonic perforation associated with
endoscopy was 3/41 (7.3%) and all cases occurred during the early phase of the study. These
mice were euthanized immediately after the procedure and excluded from analysis. Successful
endoscopic injections into the colon wall were performed using the custom-made systems de-
scribed above (Fig 1A-1C).
Proper injection of Spot into the submucosal layer was visualized endoscopically by the ap-
pearance of a mucosal wheal (Fig 3A and 3B, S1 Video). Mice were re-scoped one week later,
confirming that the site of injection could be easily identified (Fig 3C). Injection into the sub-
mucosal layer was confirmed by subsequent histologic evaluation (Fig 3D). While the custom-
made 30-gauge needle was able to reliably enter the submucosal space, the needle tip was too
large for lamina propria injections. Therefore, capillary tubes were pulled and beveled, as out-
lined in Methods, to create a needle tip that was roughly 5 μm in diameter. Using this, lamina
propria injections were also performed with Spot and were identified by the endoscopic ap-
pearance of sub-epithelial ink that did not wash away (Fig 4A). As with the submucosal injec-
tions, the inked area could be readily re-identified upon repeat colonoscopy at 1 week (Fig 4B),
and injection into the lamina propria was confirmed histologically (Fig 4C).
Implantation of Primary Mouse Colonic Myofibroblasts
Primary mouse myofibroblasts were isolated and grown in cell culture, as described in Meth-
ods. After the addition of 1.5% Spot, myofibroblast cell suspensions were injected at 5x105
cells/mL into the submucosa. Submucosal delivery of the injectate was confirmed with the ob-
servation of a submucosal wheal in real time. A follow up colonoscopy at 1 week identified an
inked area with a submucosal bulge (Fig 3C). H&E staining of histology sections revealed that
the normal bowel wall architecture was not disrupted at the injection site, there was minimal
infiltration of immune cell populations (Fig 3D), and the cells within this inked submucosal re-
gion stained positively for α-SMA (Fig 3E), suggesting successful engraftment of the injected
myofibroblasts. Overall, 3/4 (75%) of the injected specimens that were histologically analyzed
showed positive engraftment in the submucosal position.
Lamina propria injections were also performed. Because of the small caliber of the injection
system, 1x106 cells/mL was the highest concentration that could be successfully injected.
Higher cell concentrations plugged the tip of the needle. Also, a much smaller volume of cell
suspension (approximately 1 μL) could be injected into the lamina propria. Mice received 2–3
injections at multiple axial levels. The inked areas could be re-identified on follow up endosco-
py at 1 week but no mucosal bulge was visible (Fig 4B).
Endoscopic Implantation of Colonic Myofibroblasts in Mouse
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Primary Mouse Myofibroblasts Maintain Short-Term Viability Following
Injection into the Lamina Propria
Having established that injections could be consistently performed in the submucosal layer of
the mouse colon wall, and that α-SMA-positive cells were present one week following injection,
we sought to implant myofibroblasts into the lamina propria just under the epithelium, where
they normally reside. To definitively establish that the α-SMA-positive cells identified on
Fig 2. Cultured FVBmouse colonic myofibroblasts: (A) brightfield, (B) fluorescence microscopic
image showing epifluorescence of GFP-positive myofibroblasts. (C) Western blot demonstrating
positive vimentin and α-SMA stain and negative desmin stain of primary mouse colonic myofibroblasts.
Positive control stain for desmin is shown to the right. Scale bar in A and B is 100 μm.
doi:10.1371/journal.pone.0127258.g002
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histologic examination were the myofibroblast cells that we injected. To do this, GFP-positive
myofibroblasts harvested from GFP-positive mice and were grown in cell culture (Fig 2B).
These cells were then endoscopically injected into wild-type C57BL6 mice, as described.
Whole-mount fluorescent microscopy on post-injection day 7 revealed that the injection sites
were indeed GFP-positive (Fig 5A). IHC staining of these sites confirmed the presence of cells
that were double-positive for GFP and α-SMA (Fig 5B) in 5/12 (41.7%) histologic samples, ex-
cluding the technically unattainable 5x106 cells/mL injections. We then quantified GFP DNA
by qPCR and as expected, one day post-injection, there were more cells in the injection sites
that receive a higher concentration of cells, but day 7 cell engraftment was similar among the
concentrations tested (Fig 5C; S1 Table).
Discussion
Very few in vivomodels exist that are capable of studying cell-cell interactions in their native
tissue environment. Primary myofibroblasts can be harvested from mouse colon and grown in
tissue culture [7,13,15], but re-implantation of primary myofibroblast cells into a syngeneic,
Fig 3. (A,B) Endoscopic view of mouse colon with a submucosally placed needle(black arrowhead; A) and immediately after injection (white
arrowheads, B). (C) Endoscopic view of mouse colon 7 days post injection (black arrowheads). (D) H&E stain of mouse colon with 1x105 cells/mL with ink
injected endoscopically into the submucosa; scale bar 100 μm. (E) Anti-α-SMA IHC of submucosally injected myofibroblasts with high power insert; scale bar
500 μm.
doi:10.1371/journal.pone.0127258.g003
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immune-competent mouse has never been reported. We describe the successful endoscopic
implantation of primary myofibroblasts that maintain short-term viability in the submucosal
layer of the mouse colon wall.
The injection and growth of primary, non-cancerous cells was previously demonstrated by
subcutaneous injection in immune-deficient mice [5]. We demonstrate that primary myofibro-
blasts can also survive when re-implanted in the wall of the mouse colon. The presence of
Fig 4. (A) Endoscopic view of mouse colon with ink injected into the lamin propria (black arrowhead). (B) Follow up colonoscopy 7 days later
confirming presence of ink in the lamina propria (black arrowheads). (C) H&E stain of mouse colon showing presence of ink in the lamina propria; scale bar
100 μm.
doi:10.1371/journal.pone.0127258.g004
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native growth factors and an intact blood supply appear sufficient to support short-term
growth. Interestingly, at 1 week post-injection the number of viable cells remained relatively
constant regardless of the concentration of cells that were initially injected (Fig 5C). Since
these are primary cells and not cancer cell lines, these findings may suggest that the growth ki-
netics of injected primary cells plateau over time, regardless of the concentration of injected
cells. However, our study is not statistically powered to address this subject and further studies
Fig 5. (A) Whole-mount epifluorescence of a segment of mouse colon injected with GFP-positive myofibroblasts surrounded by a rim of black ink
(white arrowheads). (B) Anti-GFP (green) and anti-α-SMA (red) stains of mouse colon injected with GFP-positive myofibroblasts; nuclei are counterstained
with DAPI (blue); merged image shows GFP and α-SMA double-positive cells. Scale bar 100 μm. (C) qPCR quantification of GFP-positive myofibroblasts
injected submucosally into mouse colon at two concentrations on post-injection days 1 and 7.
doi:10.1371/journal.pone.0127258.g005
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are needed to evaluate the long-term viability and growth kinetics of the submucosally
injected cells.
Endoscopic cell microinjection creates small patches of colon containing myofibroblasts
that can be genetically altered prior to re-implantation. This was well-demonstrated with the
GFP-positive myofibroblasts that were isolated from a transgenic mouse. This approach can be
used to study how specific changes in myofibroblast function (i.e., cell signaling events, protein
expression) affect the overlying epithelium under a variety of conditions. The technique allows
for targeted manipulation of a subpopulation of myofibroblasts in a segment of mouse colon
that can be easily re-identified, serially evaluated (both endoscopically and histologically), and
directly compared to adjacent tissue under the same experimental conditions. The ability to in-
ject multiple sites in the same animal allows for a direct comparison of a specific intervention
in an identical host, as each animal will serve as its own control. This technique can be applied
to any existing mouse model, and any mouse strain, to study the contribution of the myofibro-
blast to a variety of processes including the regulation of the intestinal stem cell niche, epithelial
repair following injury, inflammatory bowel disease, and the development and progression of
cancer [10,11].
While this approach shows promise, there were a number of limitations to the study. First,
we demonstrate only short-term survival of colonic myofibroblasts; long-term survival includ-
ing the possibility of differentiation and reverse differentiation of the primary myofibroblasts
need to be carefully evaluated [7]. Use of GFP positive myofibroblasts will facilitate the identifi-
cation of implanted cells in this setting, as demonstrated here. Future directions include func-
tional assays to determine whether physiologic interactions occur between the implanted
myofibroblasts and the overlying epithelium.
In conclusion, primary myofibroblasts are capable of re-implantation in the submucosal
layer of the mouse colon wall and appear to remain viable in the short term. While long-term
viability and functional studies are required, this approach shows promise as a tool to study
stromal-epithelial interactions in an in vivo setting.
Supporting Information
S1 Fig. (A-C) Immunostaining of cultured C57BL/6-Tg(CAG-EGFP)1Osb/J mouse colonic
myofibroblasts: (A) α-SMA, (B) vimentin, and (C) desmin, scale bar 200 μm. (D) Mouse
small intestine stained with α-SMA and vimentin (scale bar 50 μm). (E) Mouse small intestine
stained with α-SMA and desmin (scale bar 20 μm). Nuclei are counterstained with DAPI.
(TIF)
S1 Video. Endoscopic injection in the submucosal layer of mouse colon.
(MP4)
S1 Table. GFP-positive ISEMFs injected at two concentrations into lamina propria quanti-
fied by qPCR on post-injection day 1 or 7.
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